Advanced search
Publication Cover
Substance Abuse and Rehabilitation Volume 6, 2015 - Issue
Submit an article Journal homepage
523
Views
26
CrossRef citations to date
0
Altmetric
Review

Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence

Kenneth M Dürsteler1 Center for Addictive Disorders, Psychiatric University Clinics Basel, Basel, Switzerland;2 Center for Addictive Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, SwitzerlandCorrespondence[email protected]
,
Eva-Maria Berger1 Center for Addictive Disorders, Psychiatric University Clinics Basel, Basel, Switzerland
,
Johannes Strasser1 Center for Addictive Disorders, Psychiatric University Clinics Basel, Basel, Switzerland
,
Carlo Caflisch2 Center for Addictive Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
,
Jochen Mutschler2 Center for Addictive Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
,
Marcus Herdener2 Center for Addictive Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
&
Marc Vogel1 Center for Addictive Disorders, Psychiatric University Clinics Basel, Basel, Switzerland
 show all
Pages 61-74 | Published online: 17 Jun 2015

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Elizabeth KC Schwartz, Noah R Wolkowicz, Joao P De Aquino, R Ross MacLean & Mehmet Sofuoglu. (2022) Cocaine Use Disorder (CUD): Current Clinical Perspectives. Substance Abuse and Rehabilitation 13, pages 25-46.
Read now
Eduardo R. Butelman & Mary Jeanne Kreek. (2017) Medications for substance use disorders (SUD): emerging approaches. Expert Opinion on Emerging Drugs 22:4, pages 301-315.
Read now
Marc Vogel, Patricia Bucher, Johannes Strasser, Matthias E. Liechti, Stephan Krähenbühl & Kenneth M. Dürsteler. (2016) Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients. Journal of Psychoactive Drugs 48:2, pages 93-100.
Read now
Mehmet Sofuoglu, Elise E. DeVito, Andrew J. Waters & Kathleen M. Carroll. (2016) Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders. Journal of Dual Diagnosis 12:1, pages 90-106.
Read now

Articles from other publishers (22)

Jie Xu, Yi Zhang, Nan Wang, Pei Sun, Fuqiang Mao & Ti-Fei Yuan. (2022) Time-dependent affective disturbances in abstinent patients with methylphenidate use disorder. BMC Psychiatry 22:1.
Crossref
Patrick Köck, Katharina Froelich, Marc Walter, Undine Lang & Kenneth M. Dürsteler. (2022) A systematic literature review of clinical trials and therapeutic applications of ibogaine. Journal of Substance Abuse Treatment 138, pages 108717.
Crossref
Carl A. Roberts, Valentina Lorenzetti, Natalia Albein-Urios, Magdalena A. Kowalczyk, Jose M. Martinez-Gonzalez & Antonio Verdejo-Garcia. (2021) Do comorbid personality disorders in cocaine dependence exacerbate neuroanatomical alterations? A structural neuroimaging study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, pages 110298.
Crossref
Joy M. Schmitz, Robert Suchting, Charles E. Green, Heather E. Webber, Jessica Vincent, F. Gerard Moeller & Scott D. Lane. (2021) The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis. Drug and Alcohol Dependence 225, pages 108800.
Crossref
Maximilian Meyer, Marc Walter, Stefan Borgwardt, Alexandra Scheidegger, Elisabeth Lang & Patrick Köck. (2021) Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder. Frontiers in Psychiatry 12.
Crossref
Laura Brandt, Thomas Chao, Sandra D. Comer & Frances R. Levin. (2020) Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?. Addiction 116:4, pages 694-710.
Crossref
Ann-Kathrin Kexel, Matthias Vonmoos, Katrin H. Preller, Lea M. Hulka, Erich Seifritz & Boris B. Quednow. (2020) Social and Non-Social Cognitive Enhancement in Cocaine Users—A Closer Look on Enhancement Motives for Cocaine Consumption. Frontiers in Psychiatry 11.
Crossref
Claire Ronsley, Seonaid Nolan, Rod Knight, Kanna Hayashi, Jano Klimas, Alex Walley, Evan Wood & Nadia Fairbairn. (2020) Treatment of stimulant use disorder: A systematic review of reviews. PLOS ONE 15:6, pages e0234809.
Crossref
MacKenzie R. Peltier & Mehmet Sofuoglu. 2020. Cognition and Addiction. Cognition and Addiction 303 320 .
Marc Vogel & Marc Walter. (2019) Opioid- und Mehrfachabhängigkeit. PSYCH up2date 13:04, pages 287-303.
Crossref
Boris B. Quednow & Marcus Herdener. 2019. Suchtmedizin. Suchtmedizin 121 142 .
Jonathan M. Wai, Frances R. Levin & Diana Martinez. 2019. The Assessment and Treatment of Addiction. The Assessment and Treatment of Addiction 1 20 .
Vítor Soares Tardelli, Mariana Pimentel Pádua do Lago, Mariel Mendez, Adam Bisaga & Thiago Marques Fidalgo. (2018) Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review. Behaviour Research and Therapy 111, pages 57-63.
Crossref
Frank N. Perkins & Kevin B. Freeman. (2018) Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug. Pharmacology Biochemistry and Behavior 164, pages 40-49.
Crossref
Jon Cook, Martyn Lloyd-Jones, Shalini Arunogiri, Edward Ogden & Yvonne Bonomo. (2017) Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review. Australian & New Zealand Journal of Psychiatry 51:9, pages 876-885.
Crossref
Marc Vogel, Kenneth M. Dürsteler, Marc Walter, Marcus Herdener & Carlos Nordt. (2017) Rethinking retention in treatment of opioid dependence—The eye of the beholder. International Journal of Drug Policy 39, pages 109-113.
Crossref
Michael Soyka & Jochen Mutschler. (2016) Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 148-161.
Crossref
Cody J. Wenthur. (2016) Classics in Chemical Neuroscience: Methylphenidate. ACS Chemical Neuroscience 7:8, pages 1030-1040.
Crossref
Marc Walter & Michael Soyka. (2016) Abstinence or maintenance treatment in substance use disorders?. Addiction 111:5, pages 775-776.
Crossref
Kenneth M Dürsteler & Marc Vogel. (2016) Effective drug therapy for cocaine dependence: a milestone. The Lancet 387:10034, pages 2171-2173.
Crossref
Joanne Csete, Adeeba Kamarulzaman, Michel Kazatchkine, Frederick Altice, Marek Balicki, Julia Buxton, Javier Cepeda, Megan Comfort, Eric Goosby, João Goulão, Carl Hart, Thomas Kerr, Alejandro Madrazo Lajous, Stephen Lewis, Natasha Martin, Daniel Mejía, Adriana Camacho, David Mathieson, Isidore Obot, Adeolu Ogunrombi, Susan Sherman, Jack Stone, Nandini Vallath, Peter Vickerman, Tomáš Zábranský & Chris Beyrer. (2016) Public health and international drug policy. The Lancet 387:10026, pages 1427-1480.
Crossref
RICHARD WILCOX. (2016) Molecular Mechanisms of Drug Abuse, Dependency and Craving. Journal of Addiction and Dependence 2:1, pages 1-12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.